SCHEMBL14978296

SCHEMBL14978296

CC(=O)c1cc(O)ccc1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
CYP3A4 P08684 1/20 0.46
MAPK1 P28482 1/20 0.46
CA12 O43570 6/20 0.43
CA1 P00915 6/20 0.43
CA2 P00918 6/20 0.43
CA7 P43166 6/20 0.43
CA9 Q16790 6/20 0.43
CA14 Q9ULX7 6/20 0.43
ALOX5 P09917 1/20 0.43
PTGS2 P35354 1/20 0.43
MAOB P27338 2/20 0.43
KDM4E B2RXH2 2/20 0.43
GLA P06280 2/20 0.43
GAA P10253 2/20 0.43
MEN1 O00255 1/20 0.43
S1PR4 O95977 1/20 0.43
MAPT P10636 1/20 0.43
MIF P14174 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687914 0.83 HSD17B1 (0.46) ALDH1A1HPGDCYP3A4MAPK1CA12
SCHEMBL7263165 0.80 CA12 (0.61) ALDH1A1CA12CA1CA2CA7
SCHEMBL1310573 0.80 MAPT (0.51) ALDH1A1HPGDMAPK1CA12CA9
SCHEMBL16520525 0.79 ALDH1A1 (0.55) ALDH1A1HPGDCYP3A4MAPK1CA12
SCHEMBL10943538 0.78 AKR1C3 (0.46) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL30844550 0.78 F2R (0.47) MAPK1KDM4EMEN1MAPTKMT2A
SCHEMBL136961 0.78 F2R (0.47) MAPK1KDM4EMEN1MAPTKMT2A
SCHEMBL22423309 0.78 ERN1 (0.47) ALDH1A1HPGDCA12CA1CA2
SCHEMBL177377 0.78 CA12 (0.67) CYP3A4CA12CA1CA2CA7
SCHEMBL30121064 0.78 CA12 (0.67) CYP3A4CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685454-B Organic compounds, mixtures, compositions and organic electronic devices 广州华睿光电材料有限公司 2024-01-12 CN disclosed
CN-114685454-A Organic compound, mixture, composition and organic electronic device 广州华睿光电材料有限公司 2022-07-01 CN disclosed
US-8450355-B2 Compounds for the treatment of inflammatory diseases MERCK SHARP & DOHME CORP. (US) 2013-05-28 US disclosed
US-20110288077-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES SCHERING CORPORATION (US) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288077-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES TNF, ADAMTS13, MMP11 ALDH1A1 1368/4885HPGD 475/4885CYP3A4 2793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.